The prenatal diagnosis of a number of inborn errors of metabolism and chromosome disorders is now possible through biochemical and cytogenetic assays on cultured amniotic-fluid cells. These techniques do not allow recognition of most congenital malVol. l
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Human serum normally contains only the conjugated bile salts, glycocholate, glycochenodeoxycholate, taurocholate and taurochenodeoxycholate (Sandberg et al., 1965 ; Panveliwalla et al., 1970) , with a total concentration below 5pmol/l. In serum from jaundiced patients the total bile salt concentration may rise to values exceeding 250pmol/l (Panveliwalla et al., 1970) . The conjugated chenodeoxycholates and free acids that we have now shown to inhibit brain respiration in vitro often account for more than half of the total bile salts and may perhaps exert an inhibitor action in vivo.
These observations may be relevant to the genesis of coma during hepatic failure, for it is known that during hepatic coma the O2 uptake of human brain is below that of normal subjects (Wechsler et al., 1954; Fazekas et al., 1956) . Although several of the metabolites that are retained in extracellular fluid during hepatic coma may inhibit respiration by rat brain slices in vitro (Walshe et al., 1958; Lascelles & Taylor, 1968) , only bile salts do so at concentrations close to those found pathologically. Ammonia, for example, will inhibit respiration by rat brain slices only when in a concentration of approx. 1000 times that of plasma, even though the plasma ammonia concentration in hepatic coma often parallels the degree of coma. Three difficulties stand in the way of accepting a role for bile salts in causing hepatic coma. First, it is not known whether bile salts pass into cerebrospinal fluid; secondly, many jaundiced patients have raised plasma concentrations of bile salts without coma supervening; thirdly, the correction of hepatic coma by treatment with high-carbohydrate regimes cannot be easily explained if bile salts are solelyresponsible for the fall of O2 uptake. For these reasons we are increasingly attracted to the possibility that more than one factor is involved.
The inhibition of respiration achieved by the conjugated bile salts parallels their detergent properties. Thus Hofmann (1963) has shown that for representative polar and non-polar compounds the conjugated deoxycholates and chenodeoxycholates have a lower critical micellar concentration and higher saturation ratio than the cholate conjugates. It is possible that the bile salts in hepatic coma permit relatively easy access to the brain of other respiratory toxins that would not themselves inhibit brain respiration in so low a concentration. In this context it is noteworthy that Lascelles &Taylor (1968) were able to show, with brain slices, potentiation of inhibition of O2 uptake by combinations of metabolites each of which was present in a concentration known not to be inhibitory.
Finally, hepatic coma is often accompanied by acute renal failure. There can be no doubt that bile salts can penetrate the glomeruli and be reabsorbed by the renal tubules. If free chenodeoxycholate were formed in hepatic disease it might perhaps inhibit renal O2 uptake and contribute to the development of acute renal failure.
BIOCMEMlCAL SOCIETY TRANSACTIONS 0 3 formations (unless associated with a chroniowmnl aberration), where both the genetics and cause are obscure. The commonest of thc congenital malformations of the central nervous system are anencephaly and spina bifida, which have incidences of up to 3.6 in 1000 in the U.K. (Elwood, 1970) . Since the risk ofeither disorder increases dramatically in families where there are already affected sibs, a proportion of high-risk pregnancies can be readily identified (Carter et d., 1966; Carter & Fraser-Roberts, 1967) .
In anencephaly there are some indications that vascular tissue on the floor of the skull is exposed to the amniotic fluid (Willis, 1958) . This might allow leakage of foetal blood and could explain the reports of elevated amniotic-fluid bilirubin concentration in this disorder (Cassady & Cailliteau, 1967; Lee & Wei, 1970) . We therefore decided to measure the concentration of a specifically foetal protein in the fluid. or-Foetoprotein was chosen since it is an exclusive product of the conceptus, being synthesized in the yolk-sac, liver and gastrointestinal tract from as early as 6 weeks of gestation (Gitlin et al., 1972) . It is known to reach maximum concentration in foetal serum at about 13-15 weeks and then to decline towards term (Gitlin & Boesman, 1966) . There have been contradictory reports about its presence in amniotic fluid (Gitlin & Boesman, 1966; Smith et al., 1971) , although by using a sensitive radioimmunoassay method Seppiila & Ruoslahti (1972) were able to detect it at all stages of gestation.
In the present study or-foetoprotein was measured by one-dimensional antibodyantigen crossed electrophoresis (Brock & Sutcliffe, 1972) . In normal pregnancies a-foetoprotein concentration in amniotic fluid was maximal at 13 weeks of gestation, declined rapidly between 15 and 20 weeks and then fell steadily towards term (Fig. 1) . In 22 pregnancies leading to anencephaly or anencephaly combined with spina bifida, where it was possible to get amniotic fluid in the third trimester, a-foetoprotein concentrations were grossly elevated. All were above 12pg/ml, and some ranged as high as 200pglrnl (Brock & SutcliKe, 1972) . When concentrations were expressed per mg of protein or per mg of albumin the distinction between anencephalic and normal fluids remained clear. In another nine 'anencephalic' pregnancies where fluid was obtained only after 35 weeks' gestation the distinction was less clear, although five of the samples had strongly raised or-foetoprotein concentrations.
Since many of the control samples used in this study were obtained from pregnancies in which there was a risk of rhesus incompatibility, it was important to establish what effect this had on amniotic-fluid a-foetoprotein concentrations. Two pregnancies were studied where at least four successive amniocenteses had been necessary to monitor foetal status. In both the degree of isoimmunization was sufficient to require postnatal transfusions, and in one intrauterine transfusions had also been necessary. In neither case was there any indication of a raised a-foetoprotein concentration (Table l) , nor was there in four cases of rhesus isoimmunization leading to intrauterine death. A variety of other conditions where there seemed a possibility of elevated amniotic-fluid a-foetoprotein concentration were tested, but in none was an abnormal value found ( Table 1) .
The problem in the prenatal diagnosis of anencephaly is to detect it early enough to allow termination of pregnancy. There are two reasons why this should now be possible. First, even though normal cc-foetoprotein concentrations in amniotic fluid are high before 20 weeks (Fig. l) , several of the anencephalic fluids between 27 and 35 weeks' gestation had a-foetoprotein concentrations well above the entire normal range. Secondly, in a case of myelocele spina bifida, fluid was obtained at 13 weeks and had an cc-foetoprotein concentration of 350pg/ml (Brock & Sutcliffe, 1972) . Since this condition resembles anencephaly in that the neural plate is exposed, one would expect even higher a-foetoprotein concentrations in early amniotic fluids from anencephalic pregnancies. ,B-hydroxylase (EC '1.14.2.1) activity in blood correlates well with the activity in the peripheral sympathetic nervous system and that the adrenal medulla plays no significant part in maintaining the enzymic activity in the blood. We have now measured the dopamine ,B-hydroxylase activity (by a new and sensitive method) in the plasma and tumour of five patients bearing phaeochromocytoma, as this tumour might be considered as an accessory adrenal medulla.
All the tumours had been confirmed by biological, clinical and anatomo-pathological observations. They were carried in ice from the operating room and frozen at -20°C within l h . For assay of dopamine p-hydroxylase activity they were thawed and homogenized in 2OOvol. of tris buffer containing Triton X-100.
Heparinized blood samples were centrifuged and the plasma was stored at -20°C. The dopamine ,B-hydroxylase activity was stable for months under these conditions.
For the measurement of dopamine p-hydroxylase activity we used a new sensitive radioassay method based on a double enzymic reaction (Bonnay et a/., 1970) . In the first step dopamine 8-hydroxylase hydroxylates the substrate (phenethylamine for tissue and tyramine for blood; Weinschilboum & Axelrod, 1971 ; Molinoff et a / . , 1971), and then the reaction products are submitted to the action of the phenylethanolamine N-methyltransferase in the presence of S-adeno~yI['~C]methionine. The labelled N-methylated product is extracted and determined by measurement of its radioactivity by liquid-scintillation counting. Table 1 shows that a significant decrease in blood dopamine P-hydroxylase activity appears 1 week after surgery. The possible exception (TYP) might be due to the unusual character of this malignant phaeochromocytoma (homovanillate-secretant and hepatic metastasis). However, there was no relation between tumour and plasma dopamine ,B-hydroxylase activities, nor between dopamine ,B-hydroxylase activities and catecholamine concentrations.
It is now well established that the adrenal medulla does not participate in maintaining dopamine p-hydroxylase activity in the blood. However, after the ablation of a phaeochromocytoma, which might be considered as an accessory adrenal medulla, the plasma enzyme activity falls significantly (by about 50 %).
Several hypotheses may be advanced to solve this apparent contradiction. First, a ghaeochromocytoma may have the specific character of releasing the enzyme into the
